NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

Topic

Health

Utilities consumer staples and healthcare
Investing in Sector ETFs: Consumer Staples, Healthcare, & Utilities

Here's what you need to know about the three defensive sectors in the S&P 500

Latest news about Health

Obesity and Weight-Loss Drugs: A New Thematic ETF Segment?

The ongoing Ozempic and weight-loss drug obsession has investors and ETF issuers turning to new ways of gaining healthcare sector exposure.

Weight-loss-drugs

Healthcare Stocks Drop on Medicare Payment Rate Surprise

Shares of major U.S. health insurers have taken a significant hit as the final 2025 Medicare Advantage plan payment rates fall short of industry expectations, raising concerns about margins.

Healthcare ETFs drop

Notable ETF Filings Recap: March 2024

Here's a look at some of the most interesting prospective ETFs awaiting regulatory review and approval as of March.

Files and documents piles

Healthcare Funds on the Rise

Health Care sector sees a modest 2023 finish after a decline in 2022, sparking renewed interest with substantial inflows this week.

refill of liquid on tubes

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Ozempic, Wegovy, and Mounjaro – here's how the latest weight-loss drugs could affect some pharmaceutical and food ETFs.

Analyzing the Potential ETF Winners & Losers from The Weight-Loss Drug Craze

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Dr. Sasha Goodman, Chief Investment Officer of VegTech Invest, joins Elysabeth Alfano, CEO of VegTech Invest to discuss what has happened to the Beyond Meat and Oatly stocks and, conversely, the large landscape of Plant-based Innovation companies in the public markets that are thriving.

Upside & Impact Ep. 4 - What Happened to the Beyond Meat and Oatly stocks?

Two biotech ETFs to watch for the rest of 2022 and beyond

Investors with a high tolerance for risk may seek to gain exposure to the growth potential of the biotech industry. We take a look at two ETFs that have rallied over the last month.

Two biotech ETFs to watch for the rest of 2022 and beyond
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

The ETF Show - New Autism-Impact ETF Launched

Asset TV

The ETF Show - New Autism-Impact ETF Launched

Defiance ETFs has launched the first ETF, $ASD, focused on the autism ecosystem, investing in companies that provide services, products, and research related to autism and neurodivergence.

Asset TV
By Asset TV · June 4, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs June 1, 2026

The ETF Industry saw 22 New Launches, 1 Ticker Change and 1 closure last week.

Tidal
By Tidal · June 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs May 20, 2026

The ETF Industry saw 44 New Launches, 3 Mutual Fund Conversions and 9 closures last week.

Tidal
By Tidal · May 19, 2026
The ETF Show - Politics Becomes Investable Trade through ETFs

Asset TV

The ETF Show - Politics Becomes Investable Trade through ETFs

Dan Weiskopf, Senior Portfolio Manager at Tidal Financial Group spoke with the ETF Show about Subversive ETFs that help investors trade like politicians.

Asset TV
By Asset TV · May 18, 2026

Browse all educational columns

The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up